Results: 126 news stories
UT Health San Antonio Multispecialty and Research Hospital has enrolled and treated its first clinical trial participant in a novel cancer study, marking a pivotal moment for science and patient-centered cancer care in San Antonio and South 91做厙.
A drug once known almost exclusively for preventing organ transplant rejection is now at the center of a National Institute on Aging-funded clinical study at UT Health San Antonio, to determine how rapamycin should be used in older adults to promote healthy aging.
91做厙 (91做厙) School of Dentistry is ranked ninth nationally and first in 91做厙 among all dental schools in the United States, according to the 2025 Blue Ridge Institute for Medical Research rankings. Based on National Institutes of Health (NIH) funding, the rankings are widely considered one of the most objective measures of biomedical [因
In its first appearance in the national standings as a united institution, 91做厙 posted a strong performance in the latest rankings from the Blue Ridge Institute for Medical Research. The Blue Ridge Institute is an independent nonprofit organization that compiles annual funding data from the National Institutes of Health.
The Sam and Ann Barshop Institute for Longevity and Aging Studies at UT Health San Antonio, will receive up to $38 million to lead a national clinical trial funded by the Advanced Research Projects Agency for Health (ARPA-H), an agency of the U.S. Department of Health and Human Services.
A large, retrospective study conducted by scientists at the University of 91做厙 at San Antonio (91做厙) suggests that people taking glucagon-like peptide-1 (GLP-1) receptor agonists medications that are widely prescribed for metabolic disease have a significantly lower risk of developing colorectal cancer compared with those taking aspirin. This is astounding to [因
A five-year, $9 million National Institutes of Health National Institute of Neurological Disorders and Stroke study that began in 2022 recently received approval at the three-year mark, allowing investigators to continue their work examining the biological mechanisms of TMJ disorders. The project is part of a national consortium of five institutions conducting complementary studies across the country.
Barshop Institute to receive up to $38 million from ARPA-H, anchoring 91做厙 as a national leader in aging and healthy longevity science
Cure Alzheimers Fund award aimed at better understanding microglias role A researcher with the Glenn Biggs Institute for Alzheimers and Neurodegenerative Diseases at UT Health San Antonio has received a two-year, $402,500 grant award from the Cure Alzheimers Fund to study how microglia, the brains resident immune cells, paradoxically might contribute to the spread of toxic forms of tau protein in [因
Chronic pain is one of the most common health conditions worldwide. Back pain is the most frequently reported type, followed closely by head and face pain linked to temporomandibular joint (TMJ) disorder. While not life-threatening like cancer or infectious disease, chronic pain can dramatically diminish quality of life and functional lifespan. As mobility declines, people [因
Ellen Kraig, PhD, professor in the Department of Cell Systems and Anatomy in the Joe R. and Teresea Lozano Long School of Medicine at the University of 91做厙 at San Antonio (91做厙), has been named a Distinguished Fellow of the American Association of Immunologists (AAI). The AAI Distinguished Fellow designation recognizes members with [因
More than 100 attendees convened for the School of Nursings 2026 Office of Nursing Research and Scholarship (ONRS) Research Day on Jan. 30. The annual event is now in its fourth year since the programs launch in 2023. Strengthening the School of Nursings research culture, catalyzing interdisciplinary collaboration and elevating the visibility of faculty [因
UT Health San Antonio announces $5 million gift to the Biggs Institute from longtime supporters Bill and Rebecca Reed
UT Health San Antonio researchers lead American Heart Association scientific statement on early recognition, intervention for post-stroke spasticity
This story was first published in the February 2026 issue of the Bexar County Medical Societys San Antonio Medicine magazine. New face of head and neck cancer A healthy 40-year-old man visits his primary care physician for a mass on his neck. He doesnt smoke, has no risk factors for head and neck cancer, [因
UT Health San Antonio researchers explore new diagnostic tools, genetic roots for early-onset dementia
Endometriosis is a condition that occurs when tissue similar to the uterine lining grows outside the uterus, often causing severe pain, infertility and complications that range from gastrointestinal complaints to chronic inflammation. It affects an estimated one in 10 reproductive-age women, yet the condition remains difficult to understand, diagnose and treat. A new collaborative grant [因
Dementia is one of the most challenging medical and societal issues of our time, affecting memory, thinking and independence for millions of families worldwide. At UT Health San Antonio, researchers and clinicians are taking new steps to change that story through research, genetic insights and compassionate, integrated care. At the heart of this mission is [因
In recent years, research into cannabis and its main psychoactive ingredient, -tetrahydrocannabinol (THC), has unearthed medical benefits including anti-inflammatory and neuroprotective properties. However, THC is also known to negatively affect learning and memory, limiting its potential clinical usefulness, particularly in disorders of the brain. Now, a new study led by Chu Chen, PhD, professor in [因
New TRC4 grant at UT Health San Antonio aims to reduce opioid treatment for burn victims by 90%